Ralston, Katherine A. P.
Phillips, Jonathan
Krause, Amrey
Hauser, Barbara
Ralston, Stuart H. http://orcid.org/0000-0002-2804-7586
Funding for this research was provided by:
Edinburgh and Lothians Health Foundation (S030820)
Scottish Government
Article History
Received: 11 November 2021
Accepted: 17 January 2022
First Online: 13 February 2022
Declarations
:
: Prof. Stuart Ralston reports research grants to his institution from Kyowa Kirin, Astra-Zeneca and non-financial support from Eli Lilly and Novartis to his institution and financial support to his institution for educational events from Pfizer, Abbvie, Kyowa Kirin, Alexion, Amgen, Cellgene, Bristol Myers Squibb, Janssen-Cilag, Novartis, Eli Lilly Thornton & Ross, Astra Zeneca, Sanofi Genzyme, Sandoz and Roche, all outside the submitted work. Dr Hauser reports research grants to her institution from Novartis and consultancy fees from UCB and Gedeon Richter outside the submitted work. Drs Katherine Ralston, Jonathan Philips and Dr Amrey Krause have no interests to declare.
: The study was approved by the East of Scotland Research Ethics Committee (REC No: 18/NE/0362) and all participants gave informed consent to taking part. The study did not involve the use of experimental animals.